Hyperliquid Strategies

Hyperliquid Strategies EBIT/Assets

Operating Income to Assets Ratio (EBIT/Assets) of Hyperliquid Strategies (PURR) as of Oct 18, 2026.

EBIT/Assets

-

Last updated:

Operating Income to Assets Ratio (EBIT/Assets) of Hyperliquid Strategies is 2026 - . Operating Income to Assets Ratio (EBIT/Assets) of Hyperliquid Strategies was 2025 - . It decreases by % lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Hyperliquid Strategies Stock analysis

What does Hyperliquid Strategies do? Hyperliquid Strategies Inc, trading under the ticker PURR with ISIN US44916Y1064, is a US-based company headquartered in New York City. The company operates within the Health Care sector, specifically in the Biotechnology industry. Hyperliquid Strategies Inc. made its initial public offering (IPO) on December 3, 2025. The company is described as a digital asset treasury company, focusing on accumulating HYPE, the native token of Hyperliquid, a high-performance blockchain designed to support financial applications. The company also has a subsidiary, Sonnet BioTherapeutics Holdings, Inc., which is an oncology-focused biotechnology firm. Sonnet BioTherapeutics operates with a proprietary platform for developing biologic drugs, including single and bifunctional action drugs. The company's primary focus is on the accumulation of HYPE, the native token of the Hyperliquid blockchain, which is positioned as a high-performance blockchain for financial applications. Hyperliquid Strategies Inc. does not provide further details on its operations, financial figures, or specific product names beyond the information provided. The company's structure includes a subsidiary dedicated to oncology research and drug development, emphasizing its dual focus on digital assets and biotechnology. Hyperliquid Strategies is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Hyperliquid Strategies stock

On Eulerpool you can find the complete historical development of Operating Income to Assets Ratio (EBIT/Assets) Hyperliquid Strategies since 2006 – with annual values, charts, and detailed analysis.

EBIT/Assets measures operating profitability relative to total assets, providing an unlevered view of asset efficiency that is comparable across capital structures.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Operating Income to Assets Ratio (EBIT/Assets)'s Hyperliquid Strategies with sector peers and the industry average to assess whether it is attractive.

To evaluate Operating Income to Assets Ratio (EBIT/Assets)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Operating Income to Assets Ratio (EBIT/Assets).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Hyperliquid Strategies

All Key Metrics — Hyperliquid Strategies